China Universal Asset Management Company’s Mineralys Therapeutics MLYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $177K | Buy |
13,090
+3,094
| +31% | +$41.9K | 0.02% | 320 |
|
|
2025
Q1 | $159K | Sell |
9,996
-557
| -5% | -$8.85K | 0.01% | 330 |
|
|
2024
Q4 | $130K | Buy |
10,553
+989
| +10% | +$12.2K | 0.01% | 368 |
|
|
2024
Q3 | $116K | Buy |
9,564
+3,732
| +64% | +$45.2K | 0.01% | 346 |
|
|
2024
Q2 | $68.2K | Sell |
5,832
-2,099
| -26% | -$24.6K | 0.01% | 332 |
|
|
2024
Q1 | $102K | Buy |
7,931
+3,181
| +67% | +$41.1K | 0.01% | 371 |
|
|
2023
Q4 | $40.9K | Buy |
+4,750
| New | +$40.9K | 0.01% | 388 |
|